---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-21-016275"
form_type: "8-K"
ticker: "HRMY"
cik: "0001802665"
company_name: "Harmony Biosciences Holdings, Inc."
filed_at: "2021-11-22T23:59:59+00:00"
generated_at: "2026-06-28T06:11:58.646754+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Harmony Biosciences appoints Linda Szyper to Board of Directors

## Summary
- Linda Szyper, former COO of McCann Health, appointed as Class II director effective Nov 18, 2021.
- She fills vacancy created by resignation of Eric L. Motley in August 2021.
- Will serve on the Nominating and Corporate Governance Committee; deemed independent under Nasdaq.
- Over 30 years experience in pharma marketing, commercialization, and healthcare communications.

## SEC filing metadata
- accession: 0001558370-21-016275
- form_type: 8-K
- ticker: HRMY
- cik: 0001802665
- company_name: Harmony Biosciences Holdings, Inc.
- filed_at: 2021-11-22T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1802665/000155837021016275/0001558370-21-016275-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1802665/000155837021016275/hrmy-20211118x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-21-016275
- JSON: https://secwatch.observer/filing/0001558370-21-016275.json
- Plain text: https://secwatch.observer/filing/0001558370-21-016275.txt

## Key facts
- Executive change
  Linda Szyper was appointed as Class II director at Harmony Biosciences Holdings, Inc..
  - Action: appointed
  - Role: Class II director
  source text: Effective November 18, 2021, the Board of Directors (the “Board”) of Harmony Biosciences Holdings, Inc. (the “Company”) appointed Linda Szyper, age 56, as a Class II director
  evidence_url: https://www.sec.gov/Archives/edgar/data/1802665/000155837021016275/0001558370-21-016275-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.